COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 254: Articles 2531-2540  | Next

Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries
Andersson, N. W., Thiesson, E. M., Pihlstrom, N., Perala, J., Faksova, K., Gram, M. A., Poukka, E., Leino, T., Ljung, R., Hviid, A.
10.1101/2024.05.08.24307058 — Posted: 2024-05-09
The Anomalous Effect of COVID-19 Pandemic Restrictions on the Duration of Untreated Psychosis (DUP)
Nicholls-Mindlin, J., Hazan, H., Zhou, B., Li, F., Ferrara, M., Levine, N., Riley, S., Karmani, S., Mathis, W. S., Keshavan, M., Srihari, V.
10.1101/2024.05.09.24306737 — Posted: 2024-05-09
varVAMP: automated pan-specific primer design for tiled full genome sequencing and qPCR of highly diverse viral pathogens.
Fuchs, J., Kleine, J., Schemmerer, M., Kreibich, J., Maier, W., Battur, N., Krannich, T., Sedaghatjoo, S., Jaki, L., Maks, A., Boehm, C., Wilhelm, C., Schulze, J., Mache, C., Berger, E., Panajotov, J., Eidenschink, L., Gruening, B., Bauswein, M., Boettcher, S., Johne, R., Wenzel, J., Hoelzer, M., Panning, M.
10.1101/2024.05.08.593102 — Posted: 2024-05-09
Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5' UTR of the viral genome
Lemak, S., Skarina, T., Flick, R., Patel, D. T., Stogios, P. J., Savchenko, A.
10.1101/2024.05.09.593331 — Posted: 2024-05-09
Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
Guerra, D., Radic, L., Brinkkemper, M., Poniman, M., van der Maas, L., Torres, J. L., Ward, A. B., Sliepen, K., Schinkel, J., Sanders, R. W., van Gils, M. J., Beaumont, T.
10.1101/2024.05.09.593284 — Posted: 2024-05-09
The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP
Cunningham, C., Macdonald, O., Schaffer, A. L., Brown, A. D., Wiedemann, M., Fisher, L., Curtis, H. J., Mehrkar, A., Higgins, R., Hulme, W. J., Speed, V., Ward, T., Croker, R., Walker, A. J., Butler-Cole, B., Andrews, C. D., Parry, J., Bates, C., Evans, D., Inglesby, P., Dillingham, I., Davy, S., Bridges, L., O'Dwyer, T., Maude, S., Smith, R., Hart, L., Goldacre, B., Bacon, S., MacKenna, B.
10.1101/2024.05.08.24306990 — Posted: 2024-05-08
Novel Deep CNNs Explore Regions, Boundaries, and Residual Learning for COVID-19 Infection Analysis in Lung CT
Khan, S. H.
10.1101/2024.05.08.24307035 — Posted: 2024-05-08
Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023
Arantes, I., Ito, K., Gomes, M. F. C., de Carvalho, F. C., de Almeida, W. A. F., Khouri, R., Miyajima, F., Wallau, G., Naveca, F. G., Pereira, E. C., COVID-19 Fiocruz Genomic Surveillance Network, , Siqueira, M. M., Resende, P. C., Bello, G.
10.1101/2024.05.07.24306998 — Posted: 2024-05-08
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins Inhibitors
Lu, X., Hu, H., Mei, L., Wang, X., Xiong, L., Zhu, Y., Liu, S., Zhao, W., Mengnisa, S., Li, L., Lin, X., Liu, J., Wang, X., Duan, Z., Lu, W., Suo, Y., Wu, X., Cui, M., Yue, J., Xu, Y.
10.1101/2024.05.08.593105 — Posted: 2024-05-08
TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo
Yan, K., Dumenil, T., Stewart, R., Bishop, C. R., Tang, B., Suhrbier, A., Rawle, D. J.
10.1101/2024.05.08.593110 — Posted: 2024-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).